H.R.3320 – To direct the Secretary of State to develop a strategy to regain observer status for Taiwan in the World Health Organization, and for other purposes

TheWeekInCongress.com (TM)

Week ending January 12, 2018

H.R.3320 – To direct the Secretary of State to develop a strategy to regain observer status for Taiwan in the World Health Organization, and for other purposes

Brief

HR 3320 directs the Secretary of State to develop a strategy to regain observer status for Taiwan in the World Health Organization

“Taiwan began seeking to participate in the WHO as an observer in 1997. In 2009, with strong support from successive United States Administrations, Congress, and like-minded WHO Member States, and during a period of improved Cross-Strait relations, Taiwan received an invitation to attend the WHA as an observer under the name “Chinese Taipei”. Taiwan received the same invitation each year until 2016, when following the election of President Tsai-Ing Wen of the Democratic Progressive Party, Taiwan’s engagement in the international community began facing increased resistance from the People’s Republic of China (PRC). Taiwan’s invitation to the 2016 WHA was received late and included new language conditioning Taiwan’s participation on the PRC’s “one China principle”. In 2017, Taiwan did not receive an invitation to the WHA.”

The bill then augments Taiwan’s current status by adding “An account of the changes and improvements the Secretary of State has made to the United States plan to endorse and obtain observer status for Taiwan at the World Health Assembly, following any annual meetings of the World Health Assembly at which Taiwan did not obtain observer status”

(Full text of H.R. 3320 congress.gov)

SponsorRep. Yoho, Ted S. [R-FL-3] (Introduced 07/19/2017)

Status: Passed House /

VOTES and FLOOR ACTION

HOUSE

On Passage: https://www.congress.gov/115/bills/hr3320/BILLS-115hr3320eh.xml

House Amendments:

Motion to recommit:

Text of the motion:

SENATE

On Passage:

Procedural Actions:

Senate Amendments:

COST AND IMPACT

Cost to the taxpayers:  Based on information from the department and the cost of similar reports, CBO estimates that implementing the bill would cost less than $500,000 over the 2018-2022 period; such spending would be subject to the availability of appropriated funds.

Pay-as-you-go requirements:  Enacting H.R. 3320 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.

Dynamic Scoring:   CBO estimates that enacting H.R. 3320 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2028.

Regulatory and Other Impact: H.R. 3320 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.

Tax Complexity:  Not applicable to this bill.

Earmark Certification:  Data not available

Duplication of programs: Data not available

Direct Rule-Making:  Data not available

Advisory Committee Statement: Data not available

Budget Authority: Data not available

Constitutional Authority:   Assumed.

 

More Bill Information:

 

Copyright 2018 Legislation News & Report, LLC

All Rights Reserved